Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition

Clinical and Experimental Allergy

Volumn 33, Issue 8, 2003, Pages 1090-1096

  Corrigan, Chris J ^a,c   Shiner, R ^b   Shakur, B H ^b   Ind, P W ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Asthma; Corticosteroid; Methotrexate; Prednisolone; T lymphocyte; Therapy

Indexed keywords

CORTICOSTEROID; METHOTREXATE; PREDNISOLONE;

ADULT; AGED; ARTICLE; ASTHMA; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; IC 50; MALE; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ASTHMA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; METHOTREXATE; MIDDLE AGED; PHYTOHEMAGGLUTININS; PREDNISOLONE; T-LYMPHOCYTES;

EID: 0043123445     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.t01-1-01723.x     Document Type: Article

References (25)

1. Busse WW. Advances in immunology: asthma. N Engl J Med 2001; 344:350-62.
2. Corrigan CJ, Hamid Q, North J et al. Peripheral blood CD4, but not CD8 T lymphocytes in patients with asthma exacerbation transcribe and translate mRNA encoding cytokines which prolong eosinophil survival in the context of a Th2 type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol 1995; 12:567-78.
3. Robinson DS, Hamid Q, Ying S et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993; 148:401-6.
4. Leung DY, Martin RJ, Szefler SJ et al. Dysregulation of interleukin-4, interleukin-5 and interferon-gamma gene expression in steroid resistant asthma. J Exp Med 1995; 181:33-40.
5. Bentley AM, Hamid Q, Robinson DS et al. Prednisolone treatment in asthma: reduction in the numbers of T cells, eosinophils, tryptase-only positive mast cells, and modulation of IL-4, IL-5 and IFN-γ cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996; 153:551-6.
6. Doi S, Gemou-Engesaeth V, Kay AB, Corrigan CJ. Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy. Clin Exp Allergy 1994; 24:854-7.
7. Corrigan CJ, Brown P, Barnes NC, Szefler SJ, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma glucocorticoid pharmacokinetics, receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144:1016-25.
8. Corrigan CJ, Brown PH, Barnes NC, Tsai JJ, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma: peripheral blood T-lymphocyte activation and a comparison of the T-lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis 1991; 144:1026-32.
9. Sher ER, Leung DY, Surs W et al. Steroid-resistant asthma: cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93:33-9.
10. Marin MG. Low-dose methotrexate spares steroid usage in steroid-dependent chronic asthmatic patients: a meta-analysis. Chest 1997; 112:29-33.
11. Aaron SD, Dales RE, Pham B. Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomised clinical trials. Respir Med 1998; 92:1059-65.
12. Shiner RJ, Nunn AJ, Chung KF, Geddes DM. Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 1990; 336:137-40.
13. Vrugt B, Wilson S, Bron A et al. Low-dose methotrexate treatment in severe glucocorticoid-dependent asthma: effect on mucosal inflammation and in vitro sensitivity to glucocorticoids of mitogen-induced T cell proliferation. Eur Respir J 2000; 15:478-85.
14. Kamada AK, Szefler SJ, Leung DYM. The growing problem of steroid resistant asthma. Drug Ther 1993; 23:55-68.
15. Barnes PJ. Molecular basis for corticosteroid action in asthma. Chem Immunol 2000; 78:72-80.
16. Fairbanks LD, Ruckemann K, Qiu Y et al. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis? Biochem J 1999; 342:143-52.
17. Morgan SL, Baggott JE, Vaughn WH et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis: a double-blind, placebo-controlled trial. Ann Intern Med 1994; 121:833-41.
18. Kremer JM, Galivan J, Streckfuss A, Kamen B. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 1986; 329:832-5.
19. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY. Combination IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T cell response to glucocorticoids. J Immunol 1993; 151:3460-6.
20. Haczku A, Alexander A, Brown P et al. The effect of dexamethasone, cyclosporin, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J Allergy Clin Immunol 1994; 93:510-19.
21. Corrigan CJ, Bungre JK, Assoufi B, Cooper AE, Seddon H, Kay AB. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. Eur Respir J 1996; 9:2077-86.
22. Glynnbarnhart AM, Erzurum SC, Leff JA et al. Effect of low-dose methotrexate on the disposition of glucocorticoids and theophylline. J Allergy Clin Immunol 1991; 88:180-6.
23. Cronstein BN. Methotrexate and its mechanism of action. Arthritis Rheum 1996; 39:1951-60.
24. Hirata S, Matsubara T, Saura R, Tateiski H, Hirohata K. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularisation by low-dose methtrexate. Arthritis Rheum 1989; 32:1065-73.
25. Hine RJ, Everson MP, Hardin JM et al. Methotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation. Rheumatol Int 1990; 10:165-9.